However, at 17 weeks of age, total tumor mass is significantly increased in mice lacking T cell-derived VEGF-A (Figure 6N), and tumorigenic progression is significantly advanced when scored histologically (Figure 6O). This evidence concerns the gene VEGFA and neoplasm.